Dr. Dokras discusses preimplantation genetic diagnosis, as well as preimplation genetic screening, at Penn Fertility Care.
Preimplantation genetic diagnosis (PGD) is a screening test used to determine if genetic or chromosomal disorders are present in embryos produced through in vitro fertilization (IVF). PGD screens embryos before they are transferred to the uterus so couples can make informed decisions about their next steps in the IVF process. Embryos unaffected by the genetic or chromosomal disorder can be selected for transfer to the uterus.
For couples undergoing IVF, PGD may be recommended when:
Thousands of clinical PGD cycles have been performed worldwide, resulting in the birth of hundreds of healthy babies.
PGD does not replace prenatal testing, such as chorionic villus sampling or amniocentesis. It provides diagnostic information based on the analysis of a single cell, so prenatal testing is still recommended and currently remains the standard of care.
Learn the step-by-step process for identifying genetic or chromosomal disorders in embryos via preimplantation genetic diagnosis.
Congratulations to the 184 Penn physicians listed below who were included in Philadelphia Magazine's Top Doctors 2016.
Penn Medicine is one of the world’s leading academic medical centers.
A clinical trial is a research study involving patient volunteers that are conducted to find safe and effective treatments for a variety of health conditions.